Pennsylvania 2023-2024 Regular Session

Pennsylvania Senate Bill SB542

Introduced
3/28/23  

Caption

Requiring health insurance policies to provide coverage for postexposure prophylaxis HIV medication.

Impact

The bill's enactment will amend state laws to require all health insurance providers to cover the costs associated with PEP HIV medication. This means that health policies issued on or after the effective date must include provisions specifically for the expenses related to acquiring these critical medications. Additionally, insurance providers will be prohibited from categorizing PEP medications into higher-cost specialty tiers solely for profit motives, which could otherwise limit access for individuals in need.

Summary

Senate Bill 542, also known as the PEP for Pennsylvania Act, mandates health insurance policies in Pennsylvania to provide coverage for postexposure prophylaxis (PEP) HIV medication. This legislation emerges as a response to the growing need for accessible preventive measures against HIV transmission, specifically for individuals who may have been exposed to the virus. By ensuring that health insurance policies include coverage for PEP, the bill aims to enhance public health protections and prevent the spread of HIV in the state.

Sentiment

The sentiment surrounding SB542 appears largely supportive, particularly among health advocacy groups and organizations focused on HIV prevention. Proponents argue that the bill represents a significant step forward in public health policy, enhancing the ability of individuals to seek preventive care without financial barriers. However, there may be some apprehension from insurance companies regarding the potential financial implications of broader mandated coverage, which could be a point of contention in discussions following the bill's introduction.

Contention

Notable points of contention in discussions around SB542 may include the debate over insurance companies' profit margins versus the public health necessity of accessible and affordable medication. Critics may voice concerns about how such mandates could impact insurance premiums or the overall cost of healthcare in Pennsylvania. Furthermore, there may be discussions surrounding the adequacy of coverage parameters and whether additional counseling requirements for receiving PEP should be mandated.

Companion Bills

No companion bills found.

Previously Filed As

PA SB541

Requiring health insurance policies to provide coverage for preexposure prophylaxis HIV medication.

PA HB1213

Requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.

PA HB1301

Requiring health insurance policies to provide coverage for pre-exposure prophylaxis and post-exposure prophylaxis HIV medication and associated laboratory tests and patient visits.

PA SB339

HIV preexposure prophylaxis and postexposure prophylaxis.

PA SB159

HIV: preexposure and postexposure prophylaxis.

PA HB970

Managed Care Organizations and Health Insurance Carriers - Prior Authorization for HIV Postexposure Prophylaxis - Prohibition

PA SB787

Managed Care Organizations and Health Insurance Carriers - Prior Authorization for HIV Postexposure Prophylaxis for Victims of Sexual Offenses - Prohibition

PA HB1007

To Authorize Pharmacists To Dispense Hiv Preexposure And Postexposure Prophylaxis.

PA SB195

Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide

PA AB2327

Postsecondary education: student health care services: HIV preexposure and postexposure prophylaxis.

Similar Bills

No similar bills found.